Table 2 Clinical and other characteristics of hypertensive patients
Variables | Total = 238 (%) | MetS | p-value | ||
|---|---|---|---|---|---|
Yes = 116 (%) | No = 122 (%) | ||||
Duration since the diagnosis of HTN | ≤5 year | 152 (63.9) | 73 (62.9) | 79 (64.8) | |
6–10 year | 53 (22.3) | 21 (18.1) | 32 (26.2) | ||
≥11 year | 33 (13.9) | 22 (19.0) | 11 (9.0) | 0.049 | |
Duration since starting anti-hypertensive agents: | No | 12 (5.0) | 7 (6.0) | 5 (4.1) | |
≤5 year | 157 (66.0) | 75 (64.7) | 82 (67.2) | ||
6–10 year | 47 (19.7) | 18 (15.5) | 29 (23.8) | ||
≥11 year | 22 (9.2) | 16 (13.8) | 6 (4.9) | 0.055 | |
Family history of chronic diseases: | No | 188 (79.0) | 84 (72.4) | 104 (85.2) | |
Diabetes | 18 (7.6) | 12 (10.3) | 6 (4.9) | ||
HTN | 32 (13.4) | 20 (17.2) | 12 (9.8) | 0.05 | |
HTN drugs combination | Not started | 12 (5.0) | 7 (6.0) | 5 (4.1) | |
Single | 72 (30.3) | 27 (23.3) | 45 (36.9) | ||
Two | 129 (54.2) | 69 (59.5) | 60 (49.2) | ||
Three | 25 (10.5) | 13 (11.2) | 12 (9.8) | 0.14 | |
Mean BMI, Kg/m2, (±SD) | 25.1 (5.0) | 27.3 (4.3) | 23.6 (4.3) | <0.0001 | |
Underweight | (<18.5 Kg/m2) | 15 (6.3) | 4 (3.4) | 11 (9.0) | |
Normal | (18.5–24.9Kg/m2) | 99 (41.6) | 30 (25.9) | 69 (56.6) | |
Overweight | (25–29.9 Kg/m2) | 83 (34.9) | 49 (42.2) | 34 (27.9) | |
Obese | (>30 Kg/m2) | 41 (17.2) | 33 (28.4) | 8 (6.6) | <0.0001 a |
Mean WC, cm (±SD) | 89.7 (11.9) | 95.4 (11.6) | 84.5 (9.8) | 0.002 | |
Mean SBP, mmHg (±SD) | 134 (18.1) | 138.7 (16.3) | 131.3 (19.1) | <0.0001 | |
Mean DBP, mmHg (±SD) | 84.9 (12.4) | 87.9 (11) | 82 (12.6) | <0.0001 | |
Mean FBS, mg/dl (±SD) | 125.3 (50.3) | 142.9 (56.9) | 108.6 (36.1) | <0.0001 | |
Mean HDL-c, mg/dl (±SD) | 43.6 (15.2) | 39.4 (14.5) | 47.6 (14.9) | <0.0001 | |
Mean TGs, mg/dl (±SD) | 207 (121) | 261 (141) | 157 (65.4) | <0.0001 | |